Why CBG Research Is So New (and Why That's Changing)
Share
If you have noticed that most CBG research is only a few years old, you are not imagining it. Cannabigerol has been in the plant the whole time. The science is new for two specific reasons, both rooted in regulation and plant chemistry.
1. Legal status until 2018
Hemp was federally illegal in the United States from the 1937 Marihuana Tax Act until the 2018 Farm Bill. For most of the 20th century, studying any cannabis-derived compound, including non-intoxicating ones like CBG and CBD, required DEA permits and was very difficult to conduct. Most US research had to use government-supplied cannabis from a single farm at the University of Mississippi, which was widely criticized as not representative of commercial products.
2. The economics of plant chemistry
CBG is sometimes called the mother cannabinoid because its acidic form (CBGA) is the precursor the hemp plant converts into THC and CBD as it matures. By harvest time, most of that CBGA has already been converted, so mature hemp typically contains less than 1% CBG. To produce CBG at scale, growers must either harvest early or selectively breed strains that retain CBGA. Both kept the cost of research material high until recently.
What changed
The 2018 Farm Bill removed the legal barriers to hemp research. New breeding made CBG far more accessible. Together, those shifts triggered a wave of CBG-specific studies starting around 2020: Penn State (2022, 2023), Yale (2025, published in PNAS), and others.
Where the field stands
In practical terms, CBG research today is roughly where CBD research was around 2013 to 2015: the foundational mechanism papers are being published, but large-scale human clinical trials are still a few years out. That makes the next three to five years of CBG literature some of the most interesting to watch.
At Steadfast Health, we build SteadCalm Micellar CBG Serum, a water-soluble CBG topical with Vitamin E for daily nerve wellness, and we keep our language matched to where the evidence actually is: research on CBG as a compound, described honestly.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.